-

Walgreens Encourages Safe Drug Disposal on National Drug Take Back Day Saturday, April 26, 2025

DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens is calling on the public to help in the fight against prescription drug abuse by participating in National Prescription Drug Take Back Day on Saturday, April 26th, 2025. Drug take-back days are reserved annually for the safe disposal of unwanted, unused, or expired medications. Walgreens has more than 1,500 kiosks across 46 states and Washington, D.C. These kiosks are a convenient way to ensure medications are not accidentally or intentionally misused.

This public service is provided at no cost, year-round, by visiting a Walgreens safe medication disposal kiosk during regular pharmacy hours. Kiosk locations can be found on Walgreens.com via the store locator. Use the search filter for ‘medication disposal kiosk’ under the pharmacy section. Walgreens pharmacies that do not have safe medication disposal kiosks offer DisposeRx, or other drug disposal options free of charge that are also available year-round upon request at the pharmacy counter.

Collected medications, such as pills and tablets, are safely disposed of at incineration facilities that are registered with the federal Drug Enforcement Administration. Since the inception of its safe medication disposal program in 2016, Walgreens has collected and properly disposed of more than 6.5 million pounds of unused prescription medications.

About Walgreens

Walgreens (www.walgreens.com) is included in the U.S. Retail Pharmacy and U.S. Healthcare segments of Walgreens Boots Alliance, Inc. (Nasdaq: WBA), an integrated healthcare, pharmacy, and retail leader with a 170-year heritage of caring for communities. WBA’s purpose is to create more joyful lives through better health. Operating nearly 9,000 retail locations across America, Puerto Rico and the U.S. Virgin Islands, Walgreens is proud to be a neighborhood health destination serving nearly 10 million customers each day. Walgreens pharmacists play a critical role in the U.S. healthcare system by providing a wide range of pharmacy and healthcare services, including those that drive equitable access to care for the nation’s underserved populations. To best meet the needs of customers and patients, Walgreens offers a true omnichannel experience, with fully integrated physical and digital platforms supported by the latest technology to deliver high-quality products and services in communities nationwide.

Walgreens

NASDAQ:WBA

Release Versions

More News From Walgreens

Walgreens Debuts PharmStart to Strengthen the Tech to Pharmacist Pipeline

DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens, the nation’s largest independent community pharmacy provider, has teamed up with Guild, the leading talent development company, to launch PharmStart, a first-of-its-kind, fully funded online education program designed to help eligible team members meet the prerequisite requirements for pharmacy school. The program aims to eliminate barriers to pursuing a PharmD degree, tapping into a new pool of talent while also addressing critical challenges in the...

Walgreens Boots Alliance Reports Fiscal 2025 Second Quarter Results

DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced financial results for the second quarter of fiscal 2025, which ended February 28, 2025. Chief Executive Officer Tim Wentworth said: “Second quarter results reflect disciplined cost management and improvement in U.S. Healthcare, which were partially offset by weaker front-end results in U.S. Retail Pharmacy, while significant legal settlements resulted in continued negative free cash flow. We remain in...

Walgreens Boots Alliance Enters into Definitive Agreement to Be Acquired by Sycamore Partners

DEERFIELD, Ill. & NEW YORK--(BUSINESS WIRE)--Walgreens Boots Alliance (NASDAQ: WBA) (the "Company" or “WBA”) today announced that it has entered into a definitive agreement to be acquired by an entity affiliated with Sycamore Partners (“Sycamore”), a private equity firm specializing in retail, consumer and distribution-related investments. The total value of the transaction represents up to $23.7 billion1. WBA shareholders will receive total consideration consisting of $11.45 per share in cash...
Back to Newsroom